Recombinant Human IL-28A Protein

<strong>Recombinant Human IL-28A Protein</strong>_x000D_ <strong>Catalog number:</strong> B2015893_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 5 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 24 kDa, monomer, non-glycosylated_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 °C_x000D_ <strong>Keywords:</strong> Cytokine Zcyto20, IFN lambda 2, IFNL2, IL 28A, IL28, IL-28, IL28A, IL-28A, Interferon lambda 2_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors Immunol Rev. 2004 Dec;202:8-32._x000D_ 2: Hasegawa K, Tagawa M, Takagi K, Tsukamoto H, Tomioka Y, Suzuki T, Nishioka Y, Ohrui T, Numasaki M. Anti-tumor immunity elicited by direct intratumoral administration of a recombinant adenovirus expressing either IL-28A/IFN-λ2 or IL-29/IFN-λ1 Cancer Gene Ther. 2016 Aug;23(8):266-77._x000D_ 3: Lu Y, Li L, Chen W, Wu M. Enhanced Anti-Tumor (Anti-Proliferation) Activity of Recombinant Human Interleukin-29 (IL-29) Mutants Using Site-Directed Mutagenesis Method Appl Biochem Biotechnol. 2015 Nov;177(5):1164-75._x000D_ 4: Suzuki T, Kawamura K, Li Q, Okamoto S, Tada Y, Tatsumi K, Shimada H, Hiroshima K, Yamaguchi N, Tagawa M. Mesenchymal stem cells are efficiently transduced with adenoviruses bearing type 35-derived fibers and the transduced cells with the IL-28A gene produces cytotoxicity to lung carcinoma cells co-cultured BMC Cancer. 2014 Sep 25;14:713._x000D_ 5: Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, Ostrander C, Dong D, Shin J, Presnell S, Fox B, Haldeman B, Cooper E, Taft D, Gilbert T, Grant FJ, Tackett M, Krivan W, McKnight G, Clegg C, Foster D, Klucher KM. IL-28, IL-29 and their class II cytokine receptor IL-28R Nat Immunol. 2003 Jan;4(1):63-8._x000D_ 6: Li M, Chen Y, Huang T, Liu Y, He S. Production, characterization, and applications of two novel monoclonal antibodies against human interleukin-28A Tissue Antigens. 2006 Dec;68(6):477-82._x000D_ 7: Megjugorac NJ, Gallagher GE, Gallagher G. IL-4 enhances IFN-lambda1 (IL-29) production by plasmacytoid DCs via monocyte secretion of IL-1Ra Blood. 2010 May 27;115(21):4185-90._x000D_ 8: Li MC, Wang HY, Wang HY, Li T, He SH. Liposome-mediated IL-28 and IL-29 expression in A549 cells and anti-viral effect of IL-28 and IL-29 on WISH cells Acta Pharmacol Sin. 2006 Apr;27(4):453-9._x000D_ 9: Bartlett NW, Dumoutier L, Renauld JC, Kotenko SV, McVey CE, Lee HJ, Smith GL. A new member of the interleukin 10-related cytokine family encoded by a poxvirus J Gen Virol. 2004 Jun;85(Pt 6):1401-1412._x000D_ <a>10: Sun H, Bi L, Zhou J, Zhou D, Liu Y, Jin G, Yan W. Modulation of the function of dendritic cells in adolescents with chronic HBV infection by IFN-λ1 Int J Clin Exp Pathol. 2015 Feb 1;8(2):1743-51. eCollection 2015.</a>_x000D_ _x000D_ <strong>Products Related to Recombinant Human IL-28A Protein can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>